author-photo

Edward Vincent Loftus

Mayo Clinic

671

Papers

37915

Citations

Citation Trend

Filter By

Papers (497) Sort By

Journal Conference Others

Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis

2019 Clinical Gastroenterology and Hepatology
Show All
- Source
- Cite
- Save
Citations (24)
P413 A simple scoring tool predicts exposure–response relationship, onset of action, response to interval shortening, and surgical risk with vedolizumab therapy for Crohn’s disease

2019 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (0)
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn’s Disease: Results of the PYRAMID Registry

2019 Inflammatory Bowel Diseases
Show All
- Source
- Cite
- Save
Citations (10)
Response to Chapman and Jones

2019 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Vedolizumab in the perioperative management of inflammatory bowel disease

2019 Current Drug Targets
Show All
- Source
- Cite
- Save
Citations (6)
P499 Efficacy and safety of 2 or 3 vedolizumab intravenous infusions as induction therapy for ulcerative colitis and Crohn’s disease: results from VISIBLE 1 and 2

2019 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (0)
Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development

2019 The Lancet Gastroenterology & Hepatology
Show All
- Source
- Cite
- Save
Citations (23)
P258 Abdominal pain and its relationship with clinical outcomes, biomarker levels, and health-related quality of life in patients with moderate to severe ulcerative colitis: data from U-ACHIEVE, a Phase 2b study of upadacitinib

2019 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (1)
Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes

2019 Inflammatory Bowel Diseases
Show All
- Source
- Cite
- Save
Citations (6)
P435 Rapidity of symptomatic and inflammatory biomarker improvements following upadacitinib induction treatment: data from the U-ACHIEVE study

2019 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (0)